EUVIMEDEUVIMED entdecken
Crossref

QbD-enabled leflunomide-transfersomal gel for topical treatment of rheumatoid arthritis

Kailas Moravkar, Rutuja Thakare, Vivek Kumawat, Sandip Sapkal, Shailesh Chalikwar, Pradip Nirbhavane

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 15695-15718

DOI: 10.1007/s00210-026-05386-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 01.05.2026. Verfasst von Kailas Moravkar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Pharmacy and Quality Assurance, R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, 425405, India. Hauptthemen laut MEDLINE: Leflunomide, Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to create innovative transfersomes (TRFs) consisting of a lipid blend and a chemical permeation enhancer for efficient transdermal delivery of leflunomide (LFN). Leflunomide, a dihydroorotate dehydrogenase inhibitor, is mainly used to manage rheumatoid arthritis (RA). Oral consumption of LFN for RA can lead to adverse systemic effects; hence, local application is advisable. To develop topical dosage form of LFN, transfersomes with improved skin permeation capabilities were fabricated. The vesicle diameter of LFN-TRF was determined to be 181.2 ± 2.17 nm, zeta potential of - 29.2 ± 0.06 mV, PDI of 0.259 ± 0.006, and encapsulation percentage (EE) of 86.5 ± 3.45%. Notably, the developed formulation exhibited slow and sustained release of up to 78.87% of LFN over 24 h. The drug permeation from the nanocarriers was found to be around 67% for the LFN-TRF-gel and 55.33% for the LFN-gel. Skin irritation assessments indicated no signs of irritation, inflammation, or toxicity, affirming the formulation's nontoxic and biocompatible characteristics. In vivo studies demonstrated higher anti-inflammatory and anti-arthritic activity than conventional gel. In summary, this study presents a viable alternative for formulating effective topical LFN preparation using transfersomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeflunomideArthritis, RheumatoidAntirheumatic AgentsAnimalsGelsAdministration, CutaneousSkin AbsorptionMaleSkinFemaleDrug Carriers

Stichwörter der Autor:innen

Central composite designLeflunomideSkin permeationTransfersomes

Substanzen

LeflunomideGelsAntirheumatic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Industrial Pharmacy and Quality Assurance, R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, 425405, India.
  • Department of Pharmacology, R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, 425405, India.
  • Department of Industrial Pharmacy and Quality Assurance, R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, 425405, India. pharmashailesh@rediffmail.com.
  • Amity Institute of Pharmacy, Amity University Haryana, Gurugram, 122413, India. pnirbhavane@ggn.amity.edu.

Zitieren

APA

Moravkar, K., Thakare, R., Kumawat, V., Sapkal, S., Chalikwar, S., & Nirbhavane, P. (2026). QbD-enabled leflunomide-transfersomal gel for topical treatment of rheumatoid arthritis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 15695-15718. https://doi.org/10.1007/s00210-026-05386-7

Vancouver

Moravkar K, Thakare R, Kumawat V, Sapkal S, Chalikwar S, Nirbhavane P. QbD-enabled leflunomide-transfersomal gel for topical treatment of rheumatoid arthritis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):15695-15718. doi:10.1007/s00210-026-05386-7

BibTeX
@article{Moravkar2026,
  author = {Moravkar, Kailas and Thakare, Rutuja and Kumawat, Vivek and Sapkal, Sandip and Chalikwar, Shailesh and Nirbhavane, Pradip},
  title = {QbD-enabled leflunomide-transfersomal gel for topical treatment of rheumatoid arthritis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {10},
  pages = {15695--15718},
  doi = {10.1007/s00210-026-05386-7}
}
Kostenlos starten →